Why Intelyra
We do not compete on their ground.
Intelyra is not an RCM platform. We are not a clearinghouse. We are not a coding tool. We are not managed services. We are the intelligence layer above all of those, interpreting clinical data in financial terms and financial requirements in clinical terms, in real time, embedded in the workflow.
That distinction determines who we compete with, and who we do not.
What makes us different
Four things no incumbent vendor can credibly claim.
Clinical and financial intelligence in one platform.
No incumbent vendor reads clinical documentation and produces financial outcomes in a unified loop. Waystar is financial. AKASA is clinical-coding. R1 is managed services. We are the only platform that does both, which is what makes the leakage they cannot see, visible.
We carry the risk.
The 90-day diagnostic. The "$1M or you owe nothing" pledge. Pricing anchored to recovered dollars, not list price. The willingness to sit on top of your incumbent vendors instead of demanding replacement. We put our money where our model is.
Show your work.
Every alert clicks through to its source document. Every appeal cites the actual CMS publication. Every dollar recovered is traceable. The argument to your board is no longer "the AI says so", it is "this NCD says so, and here is the document."
Built for the hospital you actually are.
Speed-first vs. quality-first claim submission, configurable per-system. Dynamic mode recommendation tied to days-cash-on-hand. Deployment that does not require a six-month IT project. Enterprise vendors ship one workflow and tell you to adapt. We adapt to you.
Versus the named players
How we position against every kind of vendor in your stack.
The principle is simple: do not fight on their ground. Name what we are; let what we are not follow naturally.
Waystar / Availity
Their position
Clearinghouses: claim volume, throughput, payer connectivity.
Our position
We sit above the clearinghouse. We tell you what to submit, whether it will be approved, and what documentation makes the difference. They move the claim; we make the claim succeed.
Optum / R1
Their position
Managed services: outsourced RCM operations at scale.
Our position
We do not take over your operations. We make the operations you already have measurably more effective. Internal team plus Intelyra outperforms their managed model on cost, control, and speed.
AKASA / Iodine
Their position
Coding and CDI point tools: clinical narrative to code.
Our position
We do coding and CDI as one module of a unified platform that also handles prior auth, denials, leakage, and quality. The intelligence loop closes; their tools end where the chart ends.
Notable / Olive (legacy)
Their position
Workflow automation: bots and process orchestration.
Our position
We are intelligence, not automation. We make the decision; the workflow follows. Automation without decision quality moves the wrong work faster.
Epic / Oracle Health (in-EHR billing)
Their position
Native EHR billing, integrated by default.
Our position
EHR billing is a system of record, not a system of intelligence. We sit on top of the EHR via FHIR and add the layer the EHR was never built to provide.
The founder advantage
Built by clinicians and operators, not consultants.
The most defensible aspect of Intelyra is not the technology stack. It is the clinical and financial depth of its founders, reflected in three categories of operational knowledge no competitor can replicate quickly.
Clinical depth
Quality measure methodology (MIPS, APP Plus, flat benchmarks, CAHPS), CDI query methodology and DRG shift analysis, home health OASIS and PDGM payment logic, prior authorization coverage criteria across NCD/LCD and commercial payer policy.
Financial depth
RCM middleware architecture (X12 EDI, FHIR R4, 278/835/277 transactions), denial reason code taxonomy and appeal strategy by payer, QPP submission mechanics, shared savings calculation and quality performance standard methodology.
Regulatory depth
CMS-0057-F implementation requirements and timeline, Da Vinci CRD/DTR/PAS implementation guides, HHVBP national expansion, CY2026 rate-setting mechanics, eCQM transition requirements.
This depth is built from years inside the systems, not from market research about them.